|

Finerenone (BAY 94-8862) Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Kerendia, Firialta

Pipeline

Phase 4: 1

Top Sponsors

  • University of Aarhus1
  • Bayer1

Indications

  • Diabetes2
  • Chronic Kidney Disease Due to Type 2 Diabetes Mellitus1
  • Type 2 Diabetes Mellitus1
  • Type 2 Diabetes Mellitus (T2DM)1
  • Cardiovascular Diseases1

Other1 trial

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
Phase 4

Multiple Locations, New Jersey1 trial

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Many Locations

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.